BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmidkonz C. Perspective on Fibroblast Activation Protein-Specific PET/CT in Fibrotic Interstitial Lung Diseases: Imaging Fibrosis-A New Paradigm for Molecular Imaging? J Nucl Med 2022;63:125-6. [PMID: 34649945 DOI: 10.2967/jnumed.121.262944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Schmidkonz C, Kuwert T, Atzinger A, Cordes M, Schett G, Ramming A, Götz T. Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging. J Nucl Med 2022;63:1786-92. [PMID: 36109182 DOI: 10.2967/jnumed.122.264205] [Reference Citation Analysis]
2 Serfling SE, Hartrampf PE, Zhi Y, Higuchi T, Rowe SP, Bundschuh L, Essler M, Buck AK, Bundschuh RA, Werner RA. Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy. Clin Nucl Med 2022. [PMID: 35439187 DOI: 10.1097/RLU.0000000000004189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]